COCP vs SBAC · rev $105.0K vs P/E 30, rev $1.42B
Cocrystal Pharma Inc (COCP) versus SBA Communications Corp (SBAC) — a side-by-side from cached financials, not a winner call.
Cocrystal Pharma Inc (COCP) is a biotechnology company listed on US.
SBA Communications Corp (SBAC) is a reit - specialty company listed on US.
Latest reported COCP revenue for 2026-06-30 was $105.0K. Net income was -$3.2M. Revenue was down 53.3% from 2026-03-31 to 2026-06-30. COCP currently screens at market cap $13.3M.
Latest reported SBAC revenue for 2026-06-30 was $1.42B. Net income was $383.6M. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
COCP currently screens at market cap $13.3M. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
Not investment advice. Open the COCP and SBAC stock pages for the full models.
Not investment advice.